To understand MEK inhibitors, imagine cancer cells as rebellious teens refusing to follow the rules. MEK (Mitogen-Activated Protein Kinase Kinase) is a key component in the MAPK/ERK pathway—a cellular "command center" that tells cells when to grow, divide, or rest. When this